IL79260A - Process and composition for activation of immune response cells to be used in the treatment of cancer,non-malignant tumors,infections,and immune deficiencies - Google Patents
Process and composition for activation of immune response cells to be used in the treatment of cancer,non-malignant tumors,infections,and immune deficienciesInfo
- Publication number
- IL79260A IL79260A IL79260A IL7926086A IL79260A IL 79260 A IL79260 A IL 79260A IL 79260 A IL79260 A IL 79260A IL 7926086 A IL7926086 A IL 7926086A IL 79260 A IL79260 A IL 79260A
- Authority
- IL
- Israel
- Prior art keywords
- cancer
- treatment
- malignant tumors
- infections
- activation
- Prior art date
Links
- 201000011510 cancer Diseases 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 4
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 230000013564 activation of immune response Effects 0.000 title 1
- 230000007812 deficiency Effects 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 230000001472 cytotoxic effect Effects 0.000 abstract 2
- 230000001965 increasing effect Effects 0.000 abstract 2
- 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001024 immunotherapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/44—Antibodies bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/48—Blood cells, e.g. leukemia or lymphoma
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/24—Interferons [IFN]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Developmental Biology & Embryology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75009185A | 1985-06-28 | 1985-06-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL79260A0 IL79260A0 (en) | 1986-09-30 |
| IL79260A true IL79260A (en) | 1990-11-29 |
Family
ID=25016458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL79260A IL79260A (en) | 1985-06-28 | 1986-06-27 | Process and composition for activation of immune response cells to be used in the treatment of cancer,non-malignant tumors,infections,and immune deficiencies |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0227809B1 (xx) |
| JP (1) | JPS62503144A (xx) |
| CN (1) | CN86104913A (xx) |
| AT (1) | ATE80802T1 (xx) |
| AU (1) | AU597265B2 (xx) |
| CA (1) | CA1341303C (xx) |
| DE (1) | DE3686811D1 (xx) |
| DK (1) | DK107787A (xx) |
| ES (1) | ES8800981A1 (xx) |
| HU (1) | HUT43495A (xx) |
| IL (1) | IL79260A (xx) |
| WO (1) | WO1987000054A1 (xx) |
| ZA (1) | ZA864769B (xx) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5192537A (en) * | 1984-03-30 | 1993-03-09 | Cellcor Inc. | Method of treating renal cell carcinoma using activated mononuclear cells, renal tumor antigen and cimetidine |
| US4894227A (en) * | 1986-08-01 | 1990-01-16 | Cetus Corporation | Composition of immunotoxins with interleukin-2 |
| US4863726A (en) * | 1987-05-29 | 1989-09-05 | Cetus Corporation | Combination therapy using immunotoxins with interleukin-2 |
| AU2925789A (en) * | 1987-12-17 | 1989-07-19 | Browning's Clinical Pathology Services Limited | Lymphokine activation of cells for adoptive immunotherapy, e.g. of hiv infection |
| US6652850B1 (en) | 1993-09-13 | 2003-11-25 | Aventis Pharmaceuticals Inc. | Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| US5834441A (en) * | 1993-09-13 | 1998-11-10 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Adeno-associated viral (AAV) liposomes and methods related thereto |
| WO1999053027A1 (en) * | 1998-04-09 | 1999-10-21 | I.D.M. Immuno-Designed Molecules | Use of monocytes derived cells and antibodies in a synergic way for optimal induction of immunotherapeutic efficiency |
| US20020168347A1 (en) * | 1998-04-09 | 2002-11-14 | Jacques Bartholeyns | Use of monocytes derived cells, antigens and antibodies for optimal induction of immunotherapeutic efficiency |
| US6868665B2 (en) | 2001-12-21 | 2005-03-22 | General Electric Company | Methods and apparatus for operating gas turbine engines |
| US7200538B2 (en) | 2003-01-15 | 2007-04-03 | General Electric Company | Methods and apparatus for modeling gas turbine engines |
-
1986
- 1986-06-25 ES ES556684A patent/ES8800981A1/es not_active Expired
- 1986-06-25 CA CA000512441A patent/CA1341303C/en not_active Expired - Fee Related
- 1986-06-26 WO PCT/US1986/001348 patent/WO1987000054A1/en active IP Right Grant
- 1986-06-26 AT AT86904562T patent/ATE80802T1/de not_active IP Right Cessation
- 1986-06-26 JP JP61503590A patent/JPS62503144A/ja active Pending
- 1986-06-26 AU AU61254/86A patent/AU597265B2/en not_active Ceased
- 1986-06-26 ZA ZA864769A patent/ZA864769B/xx unknown
- 1986-06-26 EP EP86904562A patent/EP0227809B1/en not_active Expired - Lifetime
- 1986-06-26 HU HU863275A patent/HUT43495A/hu unknown
- 1986-06-26 DE DE8686904562T patent/DE3686811D1/de not_active Expired - Lifetime
- 1986-06-27 IL IL79260A patent/IL79260A/xx not_active IP Right Cessation
- 1986-06-28 CN CN198686104913A patent/CN86104913A/zh active Pending
-
1987
- 1987-03-02 DK DK107787A patent/DK107787A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0227809B1 (en) | 1992-09-23 |
| EP0227809A1 (en) | 1987-07-08 |
| ATE80802T1 (de) | 1992-10-15 |
| HUT43495A (en) | 1987-11-30 |
| CN86104913A (zh) | 1987-05-27 |
| AU6125486A (en) | 1987-01-30 |
| IL79260A0 (en) | 1986-09-30 |
| DK107787D0 (da) | 1987-03-02 |
| DE3686811D1 (de) | 1992-10-29 |
| JPS62503144A (ja) | 1987-12-17 |
| EP0227809A4 (en) | 1987-10-19 |
| WO1987000054A1 (en) | 1987-01-15 |
| ZA864769B (en) | 1987-02-25 |
| DK107787A (da) | 1987-03-02 |
| ES8800981A1 (es) | 1987-12-01 |
| AU597265B2 (en) | 1990-05-31 |
| ES556684A0 (es) | 1987-12-01 |
| CA1341303C (en) | 2001-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8103976A1 (es) | Un metodo de producir proteinas de interferon humano de for-ma le | |
| IL84285A0 (en) | Polynucleotide molecule,chimeric antibody with specificity to human tumor antigen,process for the preparation thereof and methods utilizing the same | |
| PH25527A (en) | N-glycosylated carboxamide derivatives | |
| HUT63063A (en) | Process for producing antibodies against cd44 cell surface glycoprotein and immunosuppressant pharmaceutical compositions comprising same | |
| EP0552296A4 (en) | Mouse monoclonal antibodies | |
| IL58775A (en) | Hydroxyethyl-azole compounds,their production and pharmaceutical compositions containing them | |
| IL79260A (en) | Process and composition for activation of immune response cells to be used in the treatment of cancer,non-malignant tumors,infections,and immune deficiencies | |
| CA963470A (en) | Derives de l'isoindoline, leur preparation et les compositions qui les contiennent | |
| HUT51594A (en) | Process for production of celates and their complexes containing ortolizating functional groups, compositions containing such active substances and process for production of conjugates consisting of one complex and linked to it antibody or fragment of antibody | |
| PH18031A (en) | Immunoglobulin conjugates,process for preparing them and pharmaceutical composition containing the same | |
| GB9009106D0 (en) | Processes and intermediates for synthetic antibody derivatives | |
| NZ237688A (en) | Antibody-cytotoxic immunoconjugate-containing compositions and cancer treatment | |
| GR3018304T3 (en) | Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4h-pyran-4-ones. | |
| ZA807985B (en) | Immunostimulating preparations based on ribosomal rna's and a process for the preparation of the rna's | |
| RU92016354A (ru) | Композиция, способы лечения, способ предупреждения рецидива, способ усиления цитотоксической активности иммунотоксина, способ усиления цитотоксического действия конъюгата | |
| PT73950A (fr) | Procede de preparation de composes de dichloredietilaminopheni-lalanine d'action antitumureuse | |
| KR960009724B1 (en) | Monoclonal antibodies against ifn-omega, process for preparing them and their use in purification | |
| NZ224502A (en) | Silyl alkylene amines and pharmaceutical use, methods for preparation and the treatment of non humans | |
| MY103593A (en) | Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation | |
| CA961042A (en) | Derives de l'isoindoline, leur preparation et les compositions medicinales qui les contiennent | |
| IE41485L (en) | Purification of protein conjugates | |
| ES2013046A6 (es) | Procedimiento para preparar una proteina marcada con un radionuclido metalico. | |
| RU93034452A (ru) | Производные хиназолинов для усиления противоопухолевой активности, способ их получения, способ лечения и фармацевтическая композиция | |
| IE862894L (en) | Pharmaceutical compositions | |
| SU1732518A1 (ru) | Способ получения иммуноглобулина м |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |